section name header

Indications ⬇

REMS


Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Interactions ⬆ ⬇

Drug-drug:

Drug-Food:

Availability ⬆ ⬇

(Generic available)

Route/Dosage ⬆ ⬇

Action ⬆ ⬇

  • Inhibits mycobacterial cell wall synthesis and interferes with metabolism.
Therapeutic effects:
  • Bacteriostatic or bactericidal action against susceptible mycobacteria.

Classifications ⬆ ⬇

Therapeutic Classification: antituberculars

Pharmacokinetics ⬆ ⬇

Absorption: Well absorbed following PO/IM administration.

Distribution: Widely distributed; readily crosses the blood-brain barrier.

Metabolism/Excretion: 50% metabolized by the liver by N-acetyltransferase (rate of acetylation is genetically determined [slow acetylators have ↑ isoniazid levels and ↑ risk of toxicity; fast acetylators have ↓ isoniazid levels and ↑ risk for treatment failure]); 50% excreted unchanged by the kidneys.

Half-Life: 1–4 hr in patients with normal renal and hepatic function; 0.5–1.6 hr in fast acetylators; 2–5 hr in slow acetylators.

Time/Action Profile ⬆ ⬇

( plasma concentrations)

ROUTEONSETPEAKDURATION
POrapid1–2 hrup to 24 hr
IMrapid1–2 hrup to 24 hr

Patient/Family Teaching ⬆ ⬇

Pronunciation ⬆ ⬇

eye-soe-NYE-a-zid

Code ⬆

NDC Code